Unable to display image

 

media@list.hc-sc.gc.ca media@list.hc-sc.gc.ca

9 août, 2007 10:13

Health Canada reviewing new safety information on cardiac events in patients taking Losec (omeprazole) or Nexium (esomeprazole)


Health Canada is advising consumers that it is currently reviewing new preliminary safety information regarding serious cardiac events in patients using Losec (omeprazole) and Nexium (esomeprazole), two prescription drugs used to treat acid-related stomach disorders. Losec and Nexium are also used to treat and prevent ulcers in the stomach and small intestine.
Omeprazole is also sold in Canada under the labels of Apo-omeprazole and Ratio-omeprazole There are no over-the-counter drug products containing omeprazole or esomeprazole authorized for marketing in Canada.

For more information, please visit:

http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2007/2007_95_e.html
Stéphane Shank


A/News Release Coordinator / Coordonnateur des communiqués

Media Relations / Relations avec les médias

Public Affairs, Consultation and Regions Branch / Direction générale des

affaires publiques, de la consultation et des régions

Health Canada / Santé Canada

Tel. / Tél.: 613.957.2974

Fax / Téléc.: 613.957.1729

delphine1939@videotron.ca | media


Go BackHomeGo Forward